Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
24-26 June, 2025
Not Confirmed
Not Confirmed
23-25 May, 2025
Not Confirmed
Not Confirmed
26-27 May, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
24-26 June, 2025
Industry Trade Show
Not Confirmed
23-25 May, 2025
Industry Trade Show
Not Confirmed
26-27 May, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/alchem-nicselect-grants-customers-royalty-free-access-to-t-max-tech-for-3-in-1-vape-satisfaction-in-flavour-restricted-markets
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/us-drug-shortages-reduce-16-yoy-in-q1-2025-cns-drugs-antimicrobials-face-highest-scarcities
17 Apr 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/04/17/3063508/0/en/Psyence-Group-Announces-Share-Consolidation.html
25 Mar 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/03/25/3048941/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedical-Further-Strengthens-Scientific-Advisory-Board-With-Appointment-of-Dr-Dan-J-Stein.html
31 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/31/2972739/0/en/Psyence-Group-Announces-Closing-of-Previously-Announced-Disposal-of-its-Stake-in-PsyLabs.html
31 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/31/2972507/0/en/Psyence-Biomedical-Announces-Closing-of-Previously-Announced-Acquisition-of-Psyence-Group-s-Stake-in-PsyLabs.html
25 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/25/2969499/0/en/Psyence-Group-s-NASDAQ-Listed-Associate-Psyence-Biomedical-Announces-Recruitment-of-Second-Clinical-Trial-Site-for-Ongoing-Phase-IIb-Clinical-Trial-of-Nature-Derived-Psilocybin-for.html
14 Oct 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/10/14/2962672/0/en/Psyence-Group-Enters-into-Debt-for-Equity-Swap-Agreement-with-its-NASDAQ-Listed-Associate-Psyence-Biomedical.html
ABOUT THIS PAGE